\
&
Contact us
\
&
Contact us
National Contact Points (NCPs) are support structures that are an essential component in the implementation of the European Framework Programmes for Research and Innovation. These support structures are funded by the 27 EU member states and the countries that are associated to the framework programme.
NCPs provide information and on the ground advice to potential applicants and beneficiaries, through the project life cycle, in a manner that would be impossible for the European Commission and the Agencies acting alone.
The National Contact Point for Horizon informs stakeholders about the Horizon Europe EU Framework Programme for Research and Innovation, running from 2021-2027, and offers support for Horizon 2020 (2014-2020) projects which are still underway.
The Commission considers NCPs to be important partners in the implementation of the programme and the main structure for providing practical information and assistance to potential participants.
NCP Flanders gives advice to all stakeholders located in Flanders (enterprises, institutes, non-profit-organisations, universities, university colleges,...). The NCP advisors are located in the Research Foundation Flanders (FWO) or Flanders Innovation and Entrepreneurship (VLAIO).
This website is an important source of information and communication channel with our stakeholders. There is a news section, event calendar and a document and video library which can be searched with key words of your choice.
For each Horizon Europe and Horizon 2020 programme part a dedicated page offers the latest information on these programmes. Cross-programme subjects are summarised in info sheets.
Flemish stakeholders can create a myHORIZON account to receive regular updates in their mail box. Examples of projects with Flemish beneficiaries are showcased via the Inspire page and testimonies throughout our website.
Outside the Horizon framework programmes many other EU funding sources on research and innovation exist which can be consulted via the EU other funding page. The EU Funding Overview is an exhaustive overview of EU funding programmes and agencies.
Please take a look around and in case you would have any question do not hesitate to get in touch with us!
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
